Jon Strum

If you’re dealing with multiple sclerosis in your life — as a patient, caregiver, family member, or friend — welcome to the RealTalk MS podcast.

[Jon Strum @RealTalkMS_jon]

https://t.co/ChXgvQ8Eka Encouraging news for people living with non-active secondary progressive MS! 🔬
We’re sharing promising clinical trial results for people with non-active secondary progressive MS, a group that still has too few treatment options.
Listen on our new FREE app for iOS and Android, or on your favorite podcast platform today!
#RealTalkMS #MultipleSclerosis #ProgressiveMS

[Jon Strum @RealTalkMS_jon]

https://t.co/ChXgvQ8Eka Two people with the same MS diagnosis may have very different disease activity and progression. So why are we still relying on broad clinical labels that don’t capture what’s really happening?
Dr. Peter Calabresi explores the case for biological disease course descriptors on RealTalk MS. 🎧
#RealTalkMS #MultipleSclerosis #MSToronto2026

[Jon Strum @RealTalkMS_jon]

https://t.co/ChXgvQ8Eka Relapsing-remitting. Secondary Progressive. Primary Progressive.
We all know these labels, but do they really tell the whole story?
Dr. Peter Calabresi explains why understanding the biology of MS could change treatment decisions, research, and the future of personalized care on RealTalk MS.
#MultipleSclerosis #RealTalkMS #MSToronto2026 @UVMResearch @UVMLarnerMed

[Jon Strum @RealTalkMS_jon]

https://t.co/ChXgvQ8Eka What if the way we describe MS is holding back progress in treating it?
Dr. Peter Calabresi @UVMLarnerMed explains why it's time to move beyond traditional disease labels and focus on the biology driving MS on RealTalk MS.
🎧 New episode out now!
#MultipleSclerosis #RealTalkMS #MSResearch #MSToronto2026

[Jon Strum @RealTalkMS_jon]

https://t.co/kNuS4WjbtN Progress in MS research doesn't happen in isolation. It takes collaboration, rigorous science, and a commitment to people affected by MS. Hear the latest from #MSToronto2026 on RealTalk MS.
#RealTalkMS #MultipleSclerosis

[Jon Strum @RealTalkMS_jon]

https://t.co/P5RWM6oO8V Missed this week's RealTalk MS? Dr. Jeffrey Cohen discusses CAR T-cell therapy, Dr. Robert Fox updates us on progressive MS research, and we explore the conversation around @1capplegate’s MS misdiagnosis.
🎧Listen now on our app, available on the Apple App Store and Google Play!
#MultipleSclerosis #RealTalkMS @ClevelandClinic @CleClinicMD

[Jon Strum @RealTalkMS_jon]

https://t.co/kNuS4WjbtN @1capplegate’s story reminds us that conversations about MS diagnosis need care, context, and trustworthy information. We’re talking about it on RealTalk MS.
#MultipleSclerosis #RealTalkMS

[Jon Strum @RealTalkMS_jon]

https://t.co/P5RWM6oO8V For people living with progressive MS, research into the mechanisms driving progression isn't abstract. It's personal.
Dr. Robert Fox discusses the global effort to move that research forward on RealTalk MS. 🎧
#MultipleSclerosis #RealTalkMS @ClevelandClinic @CleClinicMD

[Jon Strum @RealTalkMS_jon]

https://t.co/P5RWM6oO8V Research headlines can sound promising. But understanding what scientists have learned—and what they still need to know—is just as important.
Hear Dr. Jeffrey Cohen discuss CAR T-cell therapy for MS on RealTalk MS.
#RealTalkMS #MultipleSclerosis #MSResearch @ClevelandClinic @CleClinicMD

[Jon Strum @RealTalkMS_jon]

https://t.co/P5RWM6oO8V 🧬 CAR-T cell therapy. 🔬 Progressive MS research. 🧡 A thoughtful conversation about MS misdiagnosis. Three important topics, one new episode of RealTalk MS.
Listen on our new FREE app for iOS and Android, or on your favorite podcast platform today!
#RealTalkMS #MultipleSclerosis

[Jon Strum @RealTalkMS_jon]

https://t.co/P5RWM6oO8V What will it take to stop MS progression? The International Progressive MS Alliance is bringing researchers together around that question. Dr. Robert Fox of the @ClevelandClinic shares an update on RealTalk MS.
#ProgressiveMS #RealTalkMS #MultipleSclerosis @CleClinicMD

[Jon Strum @RealTalkMS_jon]

https://t.co/P5RWM6oO8V Getting an MS diagnosis can be a long and complicated journey. When a celebrity shares a story about misdiagnosis, it can bring up a lot of uncertainty.
We’re talking about how to make sense of those headlines on RealTalk MS.
#RealTalkMS #MultipleSclerosis

[Jon Strum @RealTalkMS_jon]

https://t.co/P5RWM6oO8V CAR T-cell therapy is generating interest in MS research. But what do the clinical findings actually tell us? Dr. Jeffrey Cohen helps separate scientific progress from unanswered questions on RealTalk MS.
#MSToronto2026 #MultipleSclerosis #RealTalkMS @ClevelandClinic @CleClinicMD

[Jon Strum @RealTalkMS_jon]

https://t.co/P5RWM6oO8V Stopping MS progression remains one of the biggest challenges in MS research. Dr. Robert Fox of the @ClevelandClinic joins us to discuss the global research efforts of the International Progressive MS Alliance on RealTalk MS. 🎧
#RealTalkMS #MultipleSclerosis #MSToronto2026 @CleClinicMD

[Jon Strum @RealTalkMS_jon]

https://t.co/kNuS4WjbtN @1capplegate’s MS misdiagnosis story has made headlines and raised questions. We’re talking about how to make sense of that news on RealTalk MS.
#MultipleSclerosis #RealTalkMS

[Jon Strum @RealTalkMS_jon]

https://t.co/P5RWM6oO8V 🧬 Could CAR-T cell therapy become a treatment for MS? Dr. Jeffrey Cohen of the @ClevelandClinic discusses the latest clinical findings from #MSToronto2026 on RealTalk MS.
🎧 Listen to the new episode now!
#MultipleSclerosis #RealTalkMS #MSResearch @CleClinicMD

[Jon Strum @RealTalkMS_jon]

https://t.co/OpyYVzHKLs The science is important, but so are the conversations about what that science means for people living with MS.
We’re sharing two perspectives in one important conversation.
Join Dr. Bruce Bebo and Kristine Werner Ozug for our #MSToronto2026 recap.
🎧 Listen to #RealTalkMS!
#MultipleSclerosis @mssociety @BeboBruce @Kristine_RTMS

[Jon Strum @RealTalkMS_jon]

https://t.co/luWojLii0v Missed the world's largest MS research conference?
We've got you covered! 🔬
Dr. Bruce Bebo discusses the research and announcements that stood out at #MSToronto2026 on RealTalk MS.
#MSToronto2026 #MultipleSclerosis #RealTalkMS @mssociety @BeboBruce

[Jon Strum @RealTalkMS_jon]

https://t.co/OpyYVzHKLs 🧡 For someone living with MS, the most important question about research is often "What could this mean for me?"
Kristine Werner Ozug brings that perspective to her firsthand recap of MSToronto 2026.
🎧 Listen to #RealTalkMS.
#MultipleSclerosis @Kristine_RTMS

[Jon Strum @RealTalkMS_jon]

https://t.co/OpyYVzHKLs 🔬 What happens when the world's leading MS researchers come together?
New ideas are challenged, evidence is examined, and conversations help shape what comes next for people affected by MS.
We're breaking down the key takeaways from #MSToronto2026 with Dr. Bruce Bebo on RealTalk MS.
#MultipleSclerosis #RealTalkMS @mssociety @BeboBruce